Cost effectiveness of expanded antenatal HIV testing in London

AIDS

Volumn 14, Issue 15, 2000, Pages 2383-2389

  Postma, M J ^a   Beck, E J ^a   Hankins, C A ^a   Mandalia, S ^a   Jager, J C ^a   De Jong Van den Berg, L T W ^a   Walters, M D S ^a   Sherr, L ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cost effectiveness analysis; England; Expanded antenatal HIV testing; Pharmaco economics

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; FIRST TRIMESTER PREGNANCY; GOVERNMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATION; PRENATAL SCREENING; PRIORITY JOURNAL; UNITED KINGDOM; VERTICAL TRANSMISSION;

ADULT; ANTI-HIV AGENTS; COSTS AND COST ANALYSIS; COUNSELING; DELIVERY, OBSTETRIC; FEMALE; FETAL DISEASES; HIV INFECTIONS; HUMANS; LONDON; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL DIAGNOSIS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0033764124     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200010200-00020     Document Type: Article

References (27)

1. Universal HIV screening of pregnant women in England: Cost effectiveness analysis
2. Cost effectiveness analysis of antenatal HIV screening in United Kingdom
3. Failure of pediatric AIDS prevention despite maternal HIV screening in Paris, France
4. Mechanisms and timing of mother-to-child transmission of HIV-1
5. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre
6. Changes in patterns of risk
7. Is HIV screening in pregnancy worthwhile: Can we afford it?
8. Pharmaco-economic evaluation of anti-retrovirals in treatment and prevention of HIV/AIDS
9. Changing cost of English HIV service provision 1996-1997
10. Risk of human immunodeficiency virus type I transmission through breastfeeding
11. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
12. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohort studies
13. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
14. European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection
15. Interpretation of cost-effectiveness analyses
16. Public Health Laboratory Services HIV infection in pregnant women giving birth in the UK - Levels of infection and proportions diagnosed
17. Selective versus universal antenatal HIV testing: Epidemiological and implementational factors in policy choice
18. Discounting and health benefits
19. An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B
20. Combination antiretroviral therapy in HIV infection; an economic perspective
21. Cost-effectiveness of HIV screening in acute care settings
22. Economic ealuation of pimary HIV prevention in injecting drug users
23. Economic analysis of needle exchange